Kedzierska et al., 2020 - Google Patents
The ABC of major histocompatibility complexes and T cell receptors in health and diseaseKedzierska et al., 2020
View PDF- Document ID
- 11438807299717049935
- Author
- Kedzierska K
- Koutsakos M
- Publication year
- Publication venue
- Viral Immunology
External Links
Snippet
A seminal discovery of major histocompatibility complex (MHC) restriction in T cell recognition by Peter Doherty and Rolf Zinkernagel has led to 45 years of exciting research on the mechanisms governing peptide MHC (pMHC) recognition by T cell receptors (TCRs) …
- 102000016266 T-Cell Antigen Receptors 0 title abstract description 80
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70539—MHC-molecules, e.g. HLA-molecules
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
- G01N33/505—Cells of the immune system involving T-cells
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kedzierska et al. | The ABC of major histocompatibility complexes and T cell receptors in health and disease | |
Lineburg et al. | CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses | |
Davey et al. | Recasting human Vδ1 lymphocytes in an adaptive role | |
D’Souza et al. | Casting a wider net: Immunosurveillance by nonclassical MHC molecules | |
Pietra et al. | The emerging role of HLA‐E‐restricted CD8+ T lymphocytes in the adaptive immune response to pathogens and tumors | |
La Gruta et al. | Primary CTL response magnitude in mice is determined by the extent of naive T cell recruitment and subsequent clonal expansion | |
Li et al. | Natural regulatory T cells and persistent viral infection | |
Yu et al. | Clonal deletion prunes but does not eliminate self-specific αβ CD8+ T lymphocytes | |
Kim et al. | Sustained interactions between T cell receptors and antigens promote the differentiation of CD4+ memory T cells | |
Cornberg et al. | Narrowed TCR repertoire and viral escape as a consequence of heterologous immunity | |
Obst | The timing of T cell priming and cycling | |
Kumar et al. | Increased sensitivity of antigen-experienced T cells through the enrichment of oligomeric T cell receptor complexes | |
Badovinac et al. | Initial T cell receptor transgenic cell precursor frequency dictates critical aspects of the CD8+ T cell response to infection | |
Hansasuta et al. | Recognition of HLA‐A3 and HLA‐A11 by KIR3DL2 is peptide‐specific | |
Miles et al. | Bias in the αβ T‐cell repertoire: implications for disease pathogenesis and vaccination | |
Jenkins et al. | On the composition of the preimmune repertoire of T cells specific for peptide–major histocompatibility complex ligands | |
Yang et al. | HLA-E–restricted, Gag-specific CD8+ T cells can suppress HIV-1 infection, offering vaccine opportunities | |
Leisegang et al. | MHC-restricted fratricide of human lymphocytes expressing survivin-specific transgenic T cell receptors | |
Rowntree et al. | SARS‐CoV‐2‐specific CD8+ T‐cell responses and TCR signatures in the context of a prominent HLA‐A* 24: 02 allomorph | |
Van Braeckel-Budimir et al. | AT cell receptor locus harbors a malaria-specific immune response gene | |
Holder et al. | Origins of natural killer cell memory: special creation or adaptive evolution | |
Bansal et al. | HLA-E–restricted HIV-1–specific CD8+ T cell responses in natural infection | |
Sharma et al. | Mucosal-associated invariant T cells develop an innate-like transcriptomic program in anti-mycobacterial responses | |
Doorduijn et al. | T cells specific for a TAP-independent self-peptide remain naïve in tumor-bearing mice and are fully exploitable for therapy | |
Dezfulian et al. | TScan-II: A genome-scale platform for the de novo identification of CD4+ T cell epitopes |